Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

    Related Conference of Vaccines for Immune Mediated Diseases

    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    November 26-27, 2024

    38th International Conference on Immunology

    Madrid, Spain
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany

    Vaccines for Immune Mediated Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in